Atai Life Sciences EBITDA Margin 2020-2024 | ATAI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Atai Life Sciences (ATAI) over the last 10 years. The current EBITDA margin for Atai Life Sciences as of December 31, 2024 is .
Atai Life Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.00B $-0.11B 0.00%
2024-06-30 $0.00B $-0.11B 0.00%
2023-12-31 $0.00B $-0.13B 0.00%
2023-09-30 $0.00B $-0.13B 0.00%
2023-06-30 $0.00B $-0.14B 0.00%
2023-03-31 $0.00B $-0.14B 0.00%
2022-09-30 $0.00B $-0.15B 0.00%
2022-06-30 $0.00B $-0.15B 0.00%
2021-12-31 $0.02B $-0.14B -675.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.282B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.479B 19.20
Encompass Health (EHC) United States $11.855B 25.13
DaVita (DVA) United States $10.870B 15.28
Chemed (CHE) United States $8.151B 25.62
Elanco Animal Health (ELAN) United States $6.466B 13.85
Option Care Health (OPCH) United States $5.168B 23.04
RadNet (RDNT) United States $4.542B 288.24
Amedisys (AMED) United States $3.101B 20.86
LifeStance Health (LFST) United States $2.283B 0.00
Addus HomeCare (ADUS) United States $2.019B 22.17
Astrana Health (ASTH) United States $1.497B 37.08
U.S Physical Therapy (USPH) United States $1.173B 30.28
Aveanna Healthcare Holdings (AVAH) United States $1.143B 65.11
Pennant (PNTG) United States $1.005B 36.92
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00